Please assess the completion status of the following clinical trial:

Trial Title: Effect of Pre-op NRT on Peri-operative Complications and Long-term Abstinence: A Pilot Trial in Patients Undergoing CABG Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient is currently smoking \>5 cigarettes/day for the past 30 days; there is no evidence that NRT is useful in those who smoke \<5cpd.~2. Patient is able to participate and willing to provide informed consent; participants will need to follow directions and adhere to the medication usage instructions as outlined in the informed consent document.~3. Patients is willing to be contacted by phone for follow up at 1 month and 6 months post-discharge; these time points will assess our final outcome of cessation at 6 months post-discharge.~Exclusion Criteria:~1. Patient is scheduled for surgery in \< 7 days; most patients need to be using NRT consistently for 2 weeks for it to be fully effective.~2. Patient is currently using a smoking cessation product (i.e. nicotine containing patch, gum, inhaler, lozenge, spray or nicotine containing electronic cigarette, varenicline, buproprion) or has used a smoking cessation aid consistently for more than 72 consecutive hours with the intent to reduce cigarette consumption or quit smoking within 30 days of the baseline Pre-admission Unit (PAU) visit; this will ensure the effects of the study patches will be assessed without any contamination from other cessation products.~3. Patient is willing to refrain from using any other cessation products (nicotine containing patch, gum, inhaler, lozenge, spray, nicotine containing electronic cigarette, varenicline, buproprion) prior to surgery; this will allow us to track the usage and side effects with the study patches.~4. Patient is allergic to the adhesive on the nicotine replacement therapy patch.~5. Patient is unable to read and understand English or French; study materials will only be supplied in these two languages.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: NO_INTERVENTION): Participants will receive 3 weeks of inactive NRT patches.
- Active (Type: ACTIVE_COMPARATOR): Participants will receive 3 weeks of active NRT patches

Based on this trial design, predict the completion outcome and termination type (if applicable).